A detailed history of Shoker Investment Counsel, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Shoker Investment Counsel, Inc. holds 10,425 shares of AMGN stock, worth $3.29 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
10,425
Previous 10,519 0.89%
Holding current value
$3.29 Million
Previous $2.99 Million 8.93%
% of portfolio
1.15%
Previous 1.07%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$262.75 - $319.31 $24,698 - $30,015
-94 Reduced 0.89%
10,425 $3.26 Million
Q1 2024

May 02, 2024

BUY
$268.87 - $324.56 $19,896 - $24,017
74 Added 0.71%
10,519 $2.99 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $5,114 - $5,769
20 Added 0.19%
10,445 $3.01 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $17,054 - $21,173
-78 Reduced 0.74%
10,425 $2.8 Million
Q2 2023

Aug 07, 2023

BUY
$214.27 - $253.37 $3,214 - $3,800
15 Added 0.14%
10,503 $2.33 Million
Q1 2023

May 03, 2023

SELL
$225.79 - $275.2 $24,159 - $29,446
-107 Reduced 1.01%
10,488 $2.54 Million
Q4 2022

Feb 10, 2023

BUY
$229.03 - $291.01 $23,590 - $29,974
103 Added 0.98%
10,595 $2.78 Million
Q3 2022

Nov 09, 2022

BUY
$224.46 - $253.15 $93,824 - $105,816
418 Added 4.15%
10,492 $2.36 Million
Q2 2022

Aug 09, 2022

BUY
$230.71 - $256.74 $74,288 - $82,670
322 Added 3.3%
10,074 $2.45 Million
Q1 2022

May 11, 2022

BUY
$219.27 - $242.57 $14,252 - $15,767
65 Added 0.67%
9,752 $2.36 Million
Q4 2021

Feb 07, 2022

SELL
$198.88 - $227.6 $1,789 - $2,048
-9 Reduced 0.09%
9,687 $2.18 Million
Q3 2021

Oct 25, 2021

BUY
$212.27 - $248.7 $9,127 - $10,694
43 Added 0.45%
9,696 $2.06 Million
Q2 2021

Jul 26, 2021

BUY
$233.58 - $259.14 $28,963 - $32,133
124 Added 1.3%
9,653 $2.35 Million
Q1 2021

May 11, 2021

SELL
$221.91 - $258.6 $40,831 - $47,582
-184 Reduced 1.89%
9,529 $2.37 Million
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $9,304 - $11,079
43 Added 0.44%
9,713 $2.23 Million
Q3 2020

Nov 09, 2020

BUY
$234.65 - $260.95 $10,089 - $11,220
43 Added 0.45%
9,670 $2.46 Million
Q2 2020

Aug 07, 2020

SELL
$197.81 - $242.74 $37,583 - $46,120
-190 Reduced 1.94%
9,627 $2.27 Million
Q1 2020

May 08, 2020

BUY
$182.24 - $241.7 $89,844 - $119,158
493 Added 5.29%
9,817 $1.99 Million
Q4 2019

Feb 12, 2020

BUY
$189.21 - $243.2 $16,461 - $21,158
87 Added 0.94%
9,324 $2.25 Million
Q3 2019

Nov 06, 2019

BUY
$174.11 - $208.62 $17,933 - $21,487
103 Added 1.13%
9,237 $1.79 Million
Q2 2019

Aug 09, 2019

SELL
$166.7 - $195.41 $8,001 - $9,379
-48 Reduced 0.52%
9,134 $1.68 Million
Q1 2019

May 13, 2019

BUY
$180.87 - $203.88 $2,713 - $3,058
15 Added 0.16%
9,182 $1.74 Million
Q4 2018

Feb 06, 2019

BUY
$178.4 - $208.25 $19,088 - $22,282
107 Added 1.18%
9,167 $1.78 Million
Q3 2018

Nov 09, 2018

SELL
$185.29 - $208.89 $10,561 - $11,906
-57 Reduced 0.63%
9,060 $1.88 Million
Q2 2018

Jul 18, 2018

SELL
$166.05 - $186.51 $11,789 - $13,242
-71 Reduced 0.77%
9,117 $1.68 Million
Q1 2018

May 09, 2018

SELL
$169.43 - $198.0 $14,401 - $16,830
-85 Reduced 0.92%
9,188 $1.57 Million
Q4 2017

Feb 12, 2018

SELL
$168.79 - $188.59 $38,484 - $42,998
-228 Reduced 2.4%
9,273 $1.61 Million
Q3 2017

Nov 09, 2017

BUY
$167.29 - $191.0 $1.59 Million - $1.81 Million
9,501
9,501 $1.77 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Shoker Investment Counsel, Inc. Portfolio

Follow Shoker Investment Counsel, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shoker Investment Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Shoker Investment Counsel, Inc. with notifications on news.